Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Karyopharm Therapeutics Inc. (KPTI)  
$1.13 0.05 (4.63%) as of 4:30 Fri 5/3


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 113,340,000
Market Cap: 128.07(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.6758 - $2.77
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Karyopharm Therapeutics is a pharmaceutical company focused on the discovery, development, and commercialization of drugs directed against nuclear transport and related targets for the treatment of cancer and other diseases. Co.'s main asset, XPOVIO® (selinexor), a Selective Inhibitors of Nuclear Export compound, is indicated for use in adult patients with multiple myeloma who have received at least one prior therapy; adult patients with relapsed or refractory multiple myeloma who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors; and for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 41,140 41,140
Total Buy Value $0 $0 $49,985 $49,985
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 255,827 267,169 308,707 975,987
Total Sell Value $306,355 $315,908 $380,503 $4,268,294
Total People Sold 6 6 6 8
Total Sell Transactions 19 22 33 58
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 592
  Page 6 of 24  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Frenkel Ran EVP, Chief Dev. Officer   •       –      –    2021-02-25 4 A $0.00 $0 D/D 22,013 104,439     -
   Shacham Sharon President & CSO   •       –      –    2021-02-25 4 A $0.00 $0 I/I 57,200 718,826     -
   Shacham Sharon President & CSO   •       –      –    2021-02-25 4 A $0.00 $0 D/D 57,200 920,152     -
   Demaree John Chief Commercial Officer   •       –      –    2021-02-25 4 A $0.00 $0 D/D 15,849 23,995     -
   Kauffman Michael Chief Executive Officer   •       •      –    2021-02-25 4 A $0.00 $0 I/I 57,200 920,152     -
   Kauffman Michael Chief Executive Officer   •       •      –    2021-02-25 4 A $0.00 $0 D/D 57,200 718,826     -
   Mason Michael SVP, CFO & Treasurer   •       –      –    2021-02-25 4 A $0.00 $0 D/D 22,013 51,755     -
   Lewis Tanya EVP, Chief Reg. Affairs   •       –      –    2021-02-25 4 A $0.00 $0 D/D 22,013 45,401     -
   Shah Jatin EVP, Chief Medical Officer   •       –      –    2021-02-18 4 S $14.83 $17,590 D/D (1,186) 51,791 31%     
   Shacham Sharon President & CSO   •       –      –    2021-02-18 4 S $14.83 $140,822 I/I (9,495) 575,126 31%     
   Shacham Sharon President & CSO   •       –      –    2021-02-18 4 S $14.83 $140,822 D/D (9,495) 776,452 31%     
   Frenkel Ran EVP, Chief Dev. Officer   •       –      –    2021-02-18 4 S $14.83 $42,818 D/D (2,887) 46,126 31%     
   Kauffman Michael Chief Executive Officer   •       •      –    2021-02-18 4 S $14.83 $140,822 I/I (9,495) 776,452 31%     
   Kauffman Michael Chief Executive Officer   •       •      –    2021-02-18 4 S $14.83 $140,822 D/D (9,495) 575,126 31%     
   Frenkel Ran EVP, Chief Dev. Officer   •       –      –    2021-02-15 4 OE $0.00 $0 D/D 9,675 49,013     -
   Kauffman Michael Chief Executive Officer   •       •      –    2021-02-15 4 OE $0.00 $0 I/I 21,800 785,947     -
   Kauffman Michael Chief Executive Officer   •       •      –    2021-02-15 4 OE $0.00 $0 D/D 21,800 584,621     -
   Shacham Sharon President & CSO   •       –      –    2021-02-15 4 OE $0.00 $0 I/I 21,800 584,621     -
   Shacham Sharon President & CSO   •       –      –    2021-02-15 4 OE $0.00 $0 D/D 21,800 785,947     -
   Shah Jatin EVP, Chief Medical Officer   •       –      –    2021-02-15 4 OE $0.00 $0 D/D 4,850 52,977     -
   Lewis Tanya EVP, Chief Reg. Affairs   •       –      –    2021-02-11 4 S $15.52 $31,752 D/D (2,046) 4,143 33%     
   Frenkel Ran EVP, Chief Dev. Officer   •       –      –    2021-02-11 4 S $15.52 $31,752 D/D (2,046) 39,338 33%     
   Kauffman Michael Chief Executive Officer   •       •      –    2021-02-11 4 S $15.52 $103,077 I/I (6,642) 764,147 33%     
   Kauffman Michael Chief Executive Officer   •       •      –    2021-02-11 4 S $15.52 $102,441 D/D (6,601) 562,821 33%     
   Shacham Sharon President & CSO   •       –      –    2021-02-11 4 S $15.52 $102,441 I/I (6,601) 562,821 33%     
  592 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 6 of 24
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us